The Royal College of Pharmacy has ended its sponsorship and exhibitor relationship with Teva UK, the British subsidiary of Israeli pharmaceutical company Teva Pharmaceuticals, following pressure from pro-Palestine activists.
The college's decision to drop Teva from its annual conference next month marks the second major UK health organisation to cut ties with the firm over concerns about the company's activities, according to The Guardian.
The source material does not specify what those activities are, which health body ended ties first, when that occurred, or what specific concerns the activists raised. The Guardian piece provides no named spokespeople from the Royal College of Pharmacy, Teva, or the campaign groups involved, and includes no direct quotations explaining the rationale for the decision.
The article confirms only that pro-Palestine campaigners applied pressure and that the college responded by withdrawing commercial support from the conference.